Explore

Trendline Trendline
Whitehead Institute Enhances Genetic Medicine Delivery with Producer Cell Modifications

Whitehead Institute Enhances Genetic Medicine Delivery with Producer Cell Modifications

Whitehead Institute Enhances Genetic Medicine Delivery with Producer Cell Modifications
Trendline Trendline
Intellia Therapeutics Begins FDA Submission for CRISPR-Based Hereditary Angioedema Treatment

Intellia Therapeutics Begins FDA Submission for CRISPR-Based Hereditary Angioedema Treatment

Intellia Therapeutics Begins FDA Submission for CRISPR-Based Hereditary Angioedema Treatment
Rapid Read Rapid Read
Intellia Therapeutics' Crispr-Based Treatment Achieves Success in Pivotal Trial

Intellia Therapeutics' Crispr-Based Treatment Achieves Success in Pivotal Trial

Intellia Therapeutics has announced that its Crispr-based treatment for hereditary angioedema has met its goals in a late-stage trial. The treatment, which edits DNA in vivo to turn off a gene causing overproduction of a peptide, reduced swelling attacks by 87% compared to a placebo. This marks a significant milestone in gene editing, as it is the first Phase 3 data for in vivo Crispr treatment. The company plans to seek FDA approval and aims to launch the treatment in the U.S. next year.
Reuters Reuters
US FDA to monitor clinical trial data in real time in pilot program aimed at speeding approvals

US FDA to monitor clinical trial data in real time in pilot program aimed at speeding approvals

By Ahmed Aboulenein WASHINGTON, April 28 (Reuters) - The U.S.
Trendline Trendline
Intellia Therapeutics Submits Biologics License Application for CRISPR-Based Treatment for Hereditary Angioedema

Intellia Therapeutics Submits Biologics License Application for CRISPR-Based Treatment for Hereditary Angioedema

Intellia Therapeutics Submits Biologics License Application for CRISPR-Based Treatment for Hereditary Angioedema
Rapid Read Rapid Read
Health Organizations Urge Election Candidates to Tackle Air Pollution in Iceland

Health Organizations Urge Election Candidates to Tackle Air Pollution in Iceland

A coalition of health organizations in Iceland is urging local election candidates to prioritize air quality improvements. The call to action comes amid ongoing concerns about particulate pollution in urban areas across the country. The coalition, which includes the Icelandic Lung Association, has highlighted the adverse effects of poor air quality, particularly on vulnerable groups such as children, the elderly, and individuals with pre-existing health conditions. Andrjes Guðmundsson, chair of the Icelandic Lung Association, emphasized the importance of addressing this issue, stating that it is unacceptable for people to fear outdoor activities or sending children to school due to air pollution. The coalition is asking candidates to outline their plans for reducing particulate matter pollution and preventing unhealthy air conditions. Responses from the candidates are expected to be published on the Lung Association's website by May 6.
Rapid Read Rapid Read
Intellia's CRISPR Treatment Shows Promise in Reducing Swelling Attacks for Rare Disease

Intellia's CRISPR Treatment Shows Promise in Reducing Swelling Attacks for Rare Disease

Intellia Therapeutics announced that its CRISPR-based gene editing treatment, lonvo-z, has shown significant efficacy in reducing swelling attacks in patients with hereditary angioedema (HAE) during a Phase 3 trial. The trial involved 80 patients, and those who received the treatment experienced an 87% reduction in attack rates compared to the placebo group. Notably, over 60% of the treated patients were entirely attack-free, in contrast to just 11% in the placebo group. This development positions lonvo-z as a potential second approved CRISPR-based medicine, following Vertex Pharmaceutical's sickle cell treatment, Casgevy. Intellia has already begun a rolling submission with regulatory agencies, aiming for approval of this in vivo treatment, which directly edits patients' DNA within their bodies.
Rapid Read Rapid Read
HIV Protein Disrupts Lung Function, Increasing Risk of COPD and Emphysema

HIV Protein Disrupts Lung Function, Increasing Risk of COPD and Emphysema

Researchers at Florida International University have discovered that the HIV protein Tat disrupts the molecular 'clock' in the lungs, leading to increased risk of emphysema and chronic obstructive pulmonary disease (COPD) in people living with HIV. This disruption causes chronic inflammation and damage to airway tissue, even in non-smokers. The study, published in Communications Biology, highlights how Tat interferes with the production of a protein essential for lung function, resulting in early signs of emphysema. The research suggests potential treatments that could reset the lung clock and reduce inflammation, offering new hope for improving outcomes for HIV patients.
Rapid Read Rapid Read
FIU Researchers Discover HIV Protein Disrupts Lung Function, Increasing COPD Risk

FIU Researchers Discover HIV Protein Disrupts Lung Function, Increasing COPD Risk

Researchers at Florida International University have identified a mechanism by which HIV increases the risk of lung diseases such as emphysema and chronic obstructive pulmonary disease (COPD) in individuals, even those who have never smoked. The study, led by Hoshang Unwalla, reveals that the HIV protein Tat disrupts the lungs' molecular 'clock,' which is crucial for regulating daily lung function and immune response. This disruption leads to chronic inflammation and damage to airway tissue, setting the stage for disease development. The research involved experiments using lung samples from HIV patients, lab-grown lung cells, and a mouse model engineered to produce Tat exclusively in the lungs. The findings suggest that targeting this pathway could potentially slow or prevent disease development.
Rapid Read Rapid Read
FIU Researchers Discover HIV Protein's Role in Increasing COPD and Emphysema Risk

FIU Researchers Discover HIV Protein's Role in Increasing COPD and Emphysema Risk

Researchers at Florida International University (FIU) have identified a mechanism by which HIV increases the risk of lung diseases such as emphysema and chronic obstructive pulmonary disease (COPD) in individuals, even those who have never smoked. The study, led by Hoshang Unwalla, reveals that the HIV protein Tat disrupts the lungs' molecular 'clock,' which is crucial for regulating daily lung function and immune response. This disruption leads to chronic inflammation and damage to airway tissue, setting the stage for lung diseases. The research involved experiments using lung samples from HIV patients, lab-grown lung cells, and a mouse model engineered to produce the Tat protein in the lungs. The findings showed that Tat increases levels of a regulatory molecule that inhibits the production of SIRT1, a protein essential for maintaining the lung's clock, resulting in increased inflammation.
Rapid Read Rapid Read
Re-engineered Human Cells Enhance Gene-Editing Particle Potency Across Delivery Systems

Re-engineered Human Cells Enhance Gene-Editing Particle Potency Across Delivery Systems

A recent study published in Nature Communications highlights advancements in gene-editing technology through the re-engineering of human cells to improve the potency of gene-editing particles. Led by Valhalla Fellow Aditya Raguram and lab technician Diana Ly at the Whitehead Institute, the research focuses on enhancing the production of virus-like particles (VLPs) used in gene editing. These particles, which mimic viruses but lack viral genes, are loaded with gene-editing tools to make precise genetic modifications. The study introduces a platform for identifying genes in human cells that influence the assembly of these particles. By disabling specific genes, researchers were able to increase the production of guide RNAs, thereby enhancing the functionality of the particles. This improvement was consistent across various gene-editing tools and delivery systems, suggesting broad applicability.
Rapid Read Rapid Read
Study Links High Fruit and Vegetable Diets to Increased Lung Cancer Risk in Young Non-Smokers

Study Links High Fruit and Vegetable Diets to Increased Lung Cancer Risk in Young Non-Smokers

A study from the University of Southern California has found a surprising link between high consumption of fruits, vegetables, and whole grains and an increased risk of lung cancer in young non-smokers. The research analyzed 187 lung cancer patients under 50, revealing that those with higher Healthy Eating Index (HEI) scores, indicating healthier diets, were more likely to develop lung cancer. The study suggests that pesticide residues on produce may contribute to this risk, as these chemicals are commonly used in agriculture to protect crops. The findings challenge the conventional belief that diets rich in fruits and vegetables are universally beneficial.